Jongkundang Bio has ranked among the top searched stocks on 6 days within the past month.
As of 10:31 AM on the 15th, Jongkundang Bio is trading at 76,500 KRW, down 4.73% from the previous day. This represents a 25.0% decline compared to December 18. Jongkundang Bio is known as a manufacturer of active pharmaceutical ingredients, primarily exporting antibiotic raw materials.
Over the past 5 days, individual investors have net sold 3,183 shares, while foreigners and institutions have net sold 1,581 shares and net bought 13,780 shares, respectively.
On January 6, Jongkundang Bio became a market topic with the headline 'Nafabaltan COVID-19 treatment drug expected to receive MFDS approval...'
※Source: AI Investment Assistant AI Rassiro
※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
